Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/11/2/177/19478192/11-2-177.pdf
Reference23 articles.
1. An adjustment to the 1997 estimate for new prostate cancers;Wingo;CA Cancer J Clin,1997
2. Cancer of the prostate;Oesterling,1997
3. Second-line hormonal therapy for advanced prostate cancer: A shifting paradigm;Small;J Clin Oncol,1997
4. Vinblastine versus vinblastine plus estramustine phosphate for patients with hormone refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network phase III trial;Hudes;J Clin Oncol,1999
5. Prospective evaluation of hidrocortisone and suramin in patients with androgen-indipendent prostate cancer;Kelly;J Clin Oncol,1995
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes and toxicity of oral Fosfestrol in metastatic castration-resistant prostate cancer—a real-world experience;ecancermedicalscience;2023-08-14
2. Adsorption of Diethylstilbestrol Drug into BNNT: DFT/TD-DFT and Spectroscopic (Excited States, UV/Vis and NMR) Studies;Letters in Organic Chemistry;2023-04
3. Hormones and antihormones in cancer chemotherapy;Medicinal Chemistry of Chemotherapeutic Agents;2023
4. Experience with using fosfestrol for treating metastatic castrate-resistant prostate cancer in resource-limited setting;Indian Journal of Medical and Paediatric Oncology;2019-01
5. The resurgence of estrogens in the treatment of castration-resistant prostate cancer;Indian Journal of Urology;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3